Justine Allard
Université libre de Bruxelles
14 Papers
12 Citations
Justine Allard is an academic researcher from Université libre de Bruxelles. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 6, co-authored 10 publications.
Chat about Author
Papers
IGF-IR: a new prognostic biomarker for human glioblastoma
Calliope Maris,Nicky D'Haene,Anne-Laure Trepant,M. Le Mercier,Sébastien Sauvage,Justine Allard,Sandrine Rorive,Pieter Demetter,Christine Decaestecker,Isabelle Salmon +9 more
TL;DR: This study suggests that IGF-IR could be an interesting target for GBM therapy by suggesting the prognostic value of both the IGF ligands’ and receptors’ expression in a cohort of human GBMs.
Pharmacological targeting of netrin-1 inhibits EMT in cancer
Justine Lengrand,I. Pastushenko,Sebastiaan Vanuytven,Yura Song,David Venet,Rahul M. Sarate,Mélanie Bellina,Virginie Moers,Alice Boinet,Alejandro Sifrim,Nicolas Rama,Benjamin Ducarouge,Jens Van Herck,Christine Dubois,Samuel Scozzaro,Sophie Lemaire,Sarah Gieskes,Sophie Bonni,Amandine Collin,Nicolas Braissand,Justine Allard,Egor P. Zindy,Christine Decaestecker,Christos Sotiriou,Isabelle Salmon,Patrick Mehlen,Thierry Voet,Agnès Bernet,Cédric Blanpain +28 more
59
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer
Philippe A. Cassier,Raúl Navaridas,Mélanie Bellina,Nicolas Rama,Benjamin Ducarouge,Hector Hernandez-Vargas,Jean-Pierre Delord,Justine Lengrand,Andrea Paradisi,Laurent Fattet,Gwenaelle Garin,H. Gheit,Cécile Dalban,I. Pastushenko,David Neves,Remy Jelin,Nicolas Gadot,Nicolas Braissand,Sophie Léon,Cyril Degletagne,Xavier Matias-Guiu,Mojgan Devouassoux-Shisheboran,Eliane Mery-Lamarche,Justine Allard,Egor P. Zindy,Christine Decaestecker,Isabelle Salmon,David Pérol,Xavier Dolcet,Isabelle Ray-Coquard,Cédric Blanpain,Agnès Bernet,Patrick Mehlen +32 more
TL;DR: The results identify netrin-1 blockade as a clinical strategy triggering both tumour debulking and EMT inhibition, thus potentially alleviating resistance to standard treatments.
57
Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells
Justine Allard,Ke Li,Xavier Moles Lopez,Stéphane Blanchard,Stéphane Blanchard,Paul Barbot,Sandrine Rorive,Christine Decaestecker,Roland Pochet,Delphine Bohl,Delphine Bohl,Angelo C. Lepore,Isabelle Salmon,Charles Nicaise,Charles Nicaise +14 more
TL;DR: This study assesses the human-species specificity of Ku80, hMito and Alu, and proposes useful biomarkers for characterizing human stem cells in xenotransplantation paradigms.
NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation
Federico Mauri,Corentin Schepkens,Gaëlle Lapouge,Benjamin Drogat,Yura Song,Ievgenia Pastushenko,Sandrine Rorive,Jeremy Blondeau,Sophie Golstein,Yacine Bareche,Marie Miglianico,Erwin Nkusi,Milena Rozzi,Virginie Moers,Audrey Brisebarre,Maylis Raphaël,Christine Dubois,Justine Allard,Benoit Durdu,Floriane Ribeiro,Christos Sotiriou,Isabelle Salmon,Jalal Vakili,Cédric Blanpain +23 more
- 01 Nov 2021
TL;DR: In this article, the authors identify NR2F2 as a key regulator of malignant cancer stem cell functions that promotes tumor renewal and restricts differentiation to sustain a malignant tumor state.
26